1812 – Transcatheter Edge-To-Edge Repair (TEER) for the treatment of severe tricuspid regurgitation (TR) using the TriClip device

New Medicare Benefits Schedule item.

Transcatheter edge to edge repair (TEER) with TriClip, is a minimally invasive procedure used to treat severe tricuspid regurgitation (TR), where a heart valve leaks and causes blood to flow backward. A small clip is placed on the valve through a vein to help it close better and reduce leakage. For patients who are high-risk for open-heart surgery and don’t respond well to medication, TEER may be a treatment option to improve heart function.

Type: Therapeutic

The heart has four valves, and the tricuspid valve is one of them. It sits between the right upper chamber (atrium) and the right lower chamber (ventricle). Its job is to make sure blood flows in the right direction. In TR, this valve doesn’t close properly. That means some blood leaks backward into the upper chamber instead of moving forward to the lungs. When this leakage is severe, it can cause serious problems. Over time, severe leakage makes the heart work harder. This can lead to heart failure, liver problems, or other complications if not treated.

The following consultation deadlines apply:

• Pre-PASC consultation deadline: Friday 7 November 2025 11:59 pm AEDT  
• Pre-MSAC consultation deadline: 

Input received after the pre-PASC deadline will be considered by MSAC.

For other ways to provide input, see how to have your say.

We welcome input from everyone. We are especially keen to hear from those with lived experience of the health condition, service or technology the applications are addressing.

Find out more about consultation.

This application will be considered at the following meetings:

• PASC meeting: 11 to 12 December 2025
• ESC meeting:
• MSAC meeting: 

Find out more about our meetings.

The outcome of this application is pending.

Find out more about:

• the MSAC process
• application types
• application timelines.